butabarbital and olopatadine intranasal each improve sedation. Stay away from or Use Alternate Drug. Coadministration will increase threat of CNS depression, which can lead to additive impairment of psychomotor performance and cause daytime impairment.
butabarbital will lower the extent or effect of fosphenytoin by influencing hepatic enzyme CYP2C9/ten metabolism. Use Caution/Watch.
butabarbital will lessen the level or effect of ramelteon by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Minimal/Importance Unidentified.
butabarbital will minimize the extent or effect of oxybutynin by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Slight/Significance Mysterious.
There won't be any enough reports in Females for determining infant hazard when employing this medication during breastfeeding. Weigh the probable Added benefits versus the likely dangers ahead of taking this medication when breastfeeding.
butabarbital will minimize the level or outcome of trazodone by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Keep an eye on.
butabarbital will minimize the extent or impact of isradipine by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Insignificant/Significance Unfamiliar.
Should you miss a dose, just take it as soon as you may. If it is almost time in your subsequent dose, choose only that dose. Usually do not acquire double or added doses.
butabarbital will decrease the level or outcome of aripiprazole by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Check.
butabarbital will minimize the level or outcome of nimodipine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Mysterious.
butabarbital will reduce read more the extent or outcome of montelukast by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Insignificant/Significance Not known.
butabarbital will lessen the extent or influence of mavacamten by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated.
butabarbital will lessen the extent or influence of etravirine by influencing hepatic enzyme CYP2C9/ten metabolism. Use Warning/Observe.
butabarbital increases results of ifosfamide by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Watch. CYP3A4 inducers might increase the metabolism of ifosfamide to its Energetic alkylating metabolites.